Innovatrix Capital Ltd

<p>Over $80 billion is spent annually on global clinical trials but this is not enough to meet the demand for medical breakthroughs. Investment is a challenge given the high risk of failure. Innovatrix was formed to enable and facilitate capital and confidence into vital drug development by transferring the risk of clinical trial failure to the insurance markets through solutions that allow for payouts covering the amount spent and triggered upon failure of a clinical trial.</p>